Basic Information
Neurosterix is a biopharmaceutical company focused on developing allosteric modulators for the treatment of neurological disorders. Our drug discovery and development platform identifies and develops allosteric modulators—molecules that increase or decrease target receptor activity by binding outside the "active site" where endogenous ligands and traditional drugs typically act. Through this platform, Neurosterix’s novel drug candidates have the potential to provide medications with higher efficacy, safety, and tolerability for patient populations suffering from underserved neurological conditions.
Neurosterix
Switzerland
15~50 people
January 01, 2024
info@neurosterix.com

